These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 7052009

  • 1. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
    Paykel ES, Rowan PR, Parker RR, Bhat AV.
    Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
    [Abstract] [Full Text] [Related]

  • 2. Phenelzine and amitriptyline: effects on symptoms of neurotic depression.
    Rowan PR, Paykel ES, Parker RR.
    Br J Psychiatry; 1982 May; 140():475-83. PubMed ID: 7049292
    [Abstract] [Full Text] [Related]

  • 3. Antidepressant specificity in atypical depression.
    Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF.
    Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
    [Abstract] [Full Text] [Related]

  • 4. Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studies.
    Ravaris CL, Robinson DS, Ives JO, Nies A, Bartlett D.
    Arch Gen Psychiatry; 1980 Sep; 37(9):1075-80. PubMed ID: 7416907
    [Abstract] [Full Text] [Related]

  • 5. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
    Kayser A, Robinson DS, Yingling K, Howard DB, Corcella J, Laux D.
    J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
    [Abstract] [Full Text] [Related]

  • 6. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG.
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [Abstract] [Full Text] [Related]

  • 7. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF.
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [Abstract] [Full Text] [Related]

  • 8. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC.
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [Abstract] [Full Text] [Related]

  • 9. Response to phenelzine among depressed patients with features of hysteroid dysphoria.
    Kayser A, Robinson DS, Nies A, Howard D.
    Am J Psychiatry; 1985 Apr; 142(4):486-8. PubMed ID: 3883817
    [Abstract] [Full Text] [Related]

  • 10. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W, Rabkin J, Stewart JW, McGrath PJ, Tricamo E, Quitkin F.
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [Abstract] [Full Text] [Related]

  • 11. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D, Davidson J, Wasik J, Mattox A.
    Neuropsychobiology; 1981 Jul; 7(3):122-6. PubMed ID: 7231652
    [Abstract] [Full Text] [Related]

  • 12. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
    Stewart JW, McGrath PJ, Quitkin FM, Harrison W, Markowitz J, Wager S, Leibowitz MR.
    Arch Gen Psychiatry; 1989 Dec; 46(12):1080-7. PubMed ID: 2686575
    [Abstract] [Full Text] [Related]

  • 13. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
    Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SG, Ocepek-Welikson K, Nunes E, Rabkin JG, Klein DF.
    Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [Abstract] [Full Text] [Related]

  • 15. An outpatient evaluation of phenelzine and imipramine.
    Davidson J, Raft D, Pelton S.
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [Abstract] [Full Text] [Related]

  • 16. Psychopharmacologic validation of atypical depression.
    Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Tricamo E, Markowitz JS, Klein DF.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [Abstract] [Full Text] [Related]

  • 17. Comparative effects of phenelzine and amitriptyline: a placebo controlled trial.
    Rowan P, Paykel ES, Parker PR, West E.
    Neuropharmacology; 1980 Dec; 19(12):1223-5. PubMed ID: 7003429
    [No Abstract] [Full Text] [Related]

  • 18. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS, Nies A, Ravaris CL, Lamborn KR.
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract] [Full Text] [Related]

  • 19. Influence of acetylator phenotype on antidepressant effects of phenelzine.
    Paykel ES, West PS, Rowan PR, Parker RR.
    Br J Psychiatry; 1982 Sep; 141():243-8. PubMed ID: 6753997
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J, Amin MM, Chouinard G, Cooper AJ, Miles JE, Remick RA, Saxena B, Secunda SK, Singh AN.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.